Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health

California Agriculture

Volumn 65, Issue 3, 2011, Pages 106-111

  Zivkovic, Angela M ^a   Telis, Natalie ^a   German, J Bruce ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUPEIDAE; JUGLANS; LINUM USITATISSIMUM;

EID: 84861372249     PISSN: 00080845     EISSN: None     Source Type: Journal    
DOI: 10.3733/ca.v065n03p106     Document Type: Article

References (37)

1. Ballantyne CM. 1999. Reducing atherothrombotic events in high-risk patients: Recent data on therapy with statins and fatty acids. Curr Atheroscler Rep 1:6-8.
2. Bouwens M, van de Rest O, Dellschaft N, et al. 2009. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 90:415-24.
3. Burdge GC, Calder PC. 2006. Dietary alpha-linolenic acid and health-related outcomes: A metabolic perspective. Nutr Res Rev 19:26-52.
4. Capanni M, Calella F, Biagini MR, et al. 2006. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study. Aliment Pharmacol Ther 23:1143-51.
5. De Caterina R, Madonna R, Massaro M. 2004. Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr Atheroscler Rep 6:485-91.
6. Donadio JV, Bergstralh EJ, Offord K P, et al. 1994. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group. Clin Nephrol 41:65-71.
7. [EAS] European Atherosclerosis Society. 1987. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 8:77-88.
8. Fassett RG, Gobe GC, Peake JM, Coombes JS. 2010. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 56:728-42.
9. Freemantle E, Vandal M, Tremblay-Mercier J, et al. 2006. Omega-3 fatty acids, energy substrates and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75:213-20.
10. Funk CD. 2001. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294:1871-5.
11. Goldberg RJ, Katz J. 2007. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129:210-23.
12. Goyens PL, Spilker ME, Zock PL, et al. 2006. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84:44-53.
13. Griffin MD, Sanders TAB, Davies IG, et al. 2006. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size and postprandial lipemia in men and postmenopausal women aged 45-70 y: The OPTILIP Study. Am J Clin Nutr 84:1290-8.
14. Harris WS, Mozaffarian D, Lefevre M, et al. 2009. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139:804-19S.
15. Hogg RJ, Lee J, Nardelli N, et al. 2006. Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: Report from the Southwest Pediatric Nephrology Study Group. Clin J Am Soc Nephrol 1:467-74.
16. Hooper L, Thompson RL, Harrison RA, et al. 2004. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev CD003177.
17. Horrocks LA, Yeo YK. 1999. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40:211-25.
18. Imig JD, Zhao X, Zaharis CZ, et al. 2005. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46:975-81.
19. Jedrychowski W, Perera F, Rauh V, et al. 2007. Fish intake during pregnancy and mercury level in cord and maternal blood at delivery: An environmental study in Poland. Int J Occup Med Environ Health 20:31-7.
20. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. 2000. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71:179-88S.
21. Liou YA, King DJ, Zibrik D, Innis SM. 2007. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 137:945-52.
22. McNamara RK, Jandacek R, Rider T, et al. 2007. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications. Schizophrenia Res 91:37-50.
23. Pawlosky RJ, Hibbeln JR, Lin Y, et al. 2003. Effects of beef-and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am J Clin Nutr 77:565-72.
24. Sanchez-Villegas A, Henríquez P, Figueiras A, et al. 2007. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 46:337-46.
25. Schaefer EJ, Bongard V, Beiser AS, et al. 2006. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol 63:1545-50.
26. Serhan CN, Savill J. 2005. Resolution of inflammation: The beginning programs the end. Nat Immunol 6:1191-7.
27. Shearer GC, Harris WS, Pedersen TL, Newman JW. 2009. Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 51(8):2074-81.
28. Simopoulos A P. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495-505.
29. Simopoulos AP. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233:674-88.
30. Simopoulos AP, Leaf A, Salem N Jr. 1999. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18:487-9.
31. Stahl LL, Snyder BD, Olsen AR, Pitt JL. 2009. Contaminants in fish tissue from US lakes and reservoirs: A national probabilistic study. Environ Monit Assess 150:3-19.
32. Sunderland EM. 2007. Mercury exposure from domestic and imported estuarine and marine fish in the U.S. seafood market. Environ Health Perspect 115:235-42.
33. Thies F, Garry JM, Yaqoob P, et al. 2003. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial. Lancet 361:477-85.
34. [USDA] US Department of Agriculture. 2011. USDA Nutrient Database. www.nal.usda.gov/fnic/foodcomp/search.
35. Ye D, Zhang D, Oltman C, et al. 2002. Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther 303:768-76.
36. Zainal Z, Longman AJ, Hurst S, et al. 2009. Relative efgicacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage 17:896-905.
37. Zhao X, Yamamoto T, Newman JW, et al. 2004. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol 15:1244-53.